Pharmacokinetics and pharmacodynamics of intra-articular isoflupredone following administration to horses with lipopolysaccharide-induced synovitis

Abstract Background Intra-articular corticosteroids, such as isoflupredone acetate, are commonly used in the treatment of joint inflammation, especially in performance horses. Following administration in a non-inflamed joints blood concentrations of isoflupredone were low and detectable for only a s...

Full description

Bibliographic Details
Main Authors: Heather K. Knych, Daniel Weiner, Linda Harrison, Daniel S. McKemie
Format: Article
Language:English
Published: BMC 2022-12-01
Series:BMC Veterinary Research
Subjects:
Online Access:https://doi.org/10.1186/s12917-022-03537-5
_version_ 1828265349964890112
author Heather K. Knych
Daniel Weiner
Linda Harrison
Daniel S. McKemie
author_facet Heather K. Knych
Daniel Weiner
Linda Harrison
Daniel S. McKemie
author_sort Heather K. Knych
collection DOAJ
description Abstract Background Intra-articular corticosteroids, such as isoflupredone acetate, are commonly used in the treatment of joint inflammation, especially in performance horses. Following administration in a non-inflamed joints blood concentrations of isoflupredone were low and detectable for only a short period of time post-administration compared to synovial fluid concentrations. For some drugs, inflammation can affect pharmacokinetics, therefore, the goal of the current study was to describe the pharmacokinetics of isoflupredone acetate following intra-articular administration using a model of acute synovitis. Secondarily, pharmacodynamic effects, including effects on joint circumference, joint flexion, and lameness following intra-articular administration of isoflupredone acetate in the experimental model were described. Methods Sixteen horses received a single intra-articular dose of 8 mg of isoflupredone acetate or saline 12 h post-administration of lipopolysaccharide. Blood and urine samples were collected up to 72 h and synovial fluid for 28 days post-administration, drug concentrations determined by liquid chromatography- mass spectrometry and pharmacokinetic analysis performed. Joint circumference, maximum angle of pain free joint flexion and lameness were evaluated prior to and post-treatment. Results The maximum isoflupredone plasma concentration was 2.45 ± 0.61 ng/mL at 2.5 ± 0.75 h and concentrations were less than the limit of quantitation by 72 h. Isoflupredone was below detectable concentrations in urine by 72 h post-administration in all horses and no longer detectable in synovial fluid by 96 h post-administration. Joint circumference was significantly decreased in the isoflupredone treatment group compared to the saline group at 24 and 48 h post drug administration. Pain free joint flexion was significantly different between the saline and isoflupredone treatment groups on day 4 post-treatment. Conclusions Synovial fluid concentrations and maximum plasma concentrations of isoflupredone differed slightly between the current study and a previous one describing administration into a non-inflamed joint, however, the detection time of isoflupredone in blood was comparable. Effects of isoflupredone on joint circumference and degree of pain free joint flexion suggest a short duration of effect with respect to alleviation of lipopolysaccharide induced synovitis, however, results of this study support future studies of the anti-inflammatory effects of intra-articular isoflupredone acetate.
first_indexed 2024-04-13T04:37:58Z
format Article
id doaj.art-891874bbc184456091bc36515244cdf6
institution Directory Open Access Journal
issn 1746-6148
language English
last_indexed 2024-04-13T04:37:58Z
publishDate 2022-12-01
publisher BMC
record_format Article
series BMC Veterinary Research
spelling doaj.art-891874bbc184456091bc36515244cdf62022-12-22T03:02:07ZengBMCBMC Veterinary Research1746-61482022-12-0118111210.1186/s12917-022-03537-5Pharmacokinetics and pharmacodynamics of intra-articular isoflupredone following administration to horses with lipopolysaccharide-induced synovitisHeather K. Knych0Daniel Weiner1Linda Harrison2Daniel S. McKemie3K.L. Maddy Equine Analytical Pharmacology Laboratory, School of Veterinary Medicine, University of CaliforniaPharmacometrics ConsultantWillow Oak EquineK.L. Maddy Equine Analytical Pharmacology Laboratory, School of Veterinary Medicine, University of CaliforniaAbstract Background Intra-articular corticosteroids, such as isoflupredone acetate, are commonly used in the treatment of joint inflammation, especially in performance horses. Following administration in a non-inflamed joints blood concentrations of isoflupredone were low and detectable for only a short period of time post-administration compared to synovial fluid concentrations. For some drugs, inflammation can affect pharmacokinetics, therefore, the goal of the current study was to describe the pharmacokinetics of isoflupredone acetate following intra-articular administration using a model of acute synovitis. Secondarily, pharmacodynamic effects, including effects on joint circumference, joint flexion, and lameness following intra-articular administration of isoflupredone acetate in the experimental model were described. Methods Sixteen horses received a single intra-articular dose of 8 mg of isoflupredone acetate or saline 12 h post-administration of lipopolysaccharide. Blood and urine samples were collected up to 72 h and synovial fluid for 28 days post-administration, drug concentrations determined by liquid chromatography- mass spectrometry and pharmacokinetic analysis performed. Joint circumference, maximum angle of pain free joint flexion and lameness were evaluated prior to and post-treatment. Results The maximum isoflupredone plasma concentration was 2.45 ± 0.61 ng/mL at 2.5 ± 0.75 h and concentrations were less than the limit of quantitation by 72 h. Isoflupredone was below detectable concentrations in urine by 72 h post-administration in all horses and no longer detectable in synovial fluid by 96 h post-administration. Joint circumference was significantly decreased in the isoflupredone treatment group compared to the saline group at 24 and 48 h post drug administration. Pain free joint flexion was significantly different between the saline and isoflupredone treatment groups on day 4 post-treatment. Conclusions Synovial fluid concentrations and maximum plasma concentrations of isoflupredone differed slightly between the current study and a previous one describing administration into a non-inflamed joint, however, the detection time of isoflupredone in blood was comparable. Effects of isoflupredone on joint circumference and degree of pain free joint flexion suggest a short duration of effect with respect to alleviation of lipopolysaccharide induced synovitis, however, results of this study support future studies of the anti-inflammatory effects of intra-articular isoflupredone acetate.https://doi.org/10.1186/s12917-022-03537-5HorseIsoflupredoneCorticosteroidPharmacokineticsPharmacodynamicsInflammation
spellingShingle Heather K. Knych
Daniel Weiner
Linda Harrison
Daniel S. McKemie
Pharmacokinetics and pharmacodynamics of intra-articular isoflupredone following administration to horses with lipopolysaccharide-induced synovitis
BMC Veterinary Research
Horse
Isoflupredone
Corticosteroid
Pharmacokinetics
Pharmacodynamics
Inflammation
title Pharmacokinetics and pharmacodynamics of intra-articular isoflupredone following administration to horses with lipopolysaccharide-induced synovitis
title_full Pharmacokinetics and pharmacodynamics of intra-articular isoflupredone following administration to horses with lipopolysaccharide-induced synovitis
title_fullStr Pharmacokinetics and pharmacodynamics of intra-articular isoflupredone following administration to horses with lipopolysaccharide-induced synovitis
title_full_unstemmed Pharmacokinetics and pharmacodynamics of intra-articular isoflupredone following administration to horses with lipopolysaccharide-induced synovitis
title_short Pharmacokinetics and pharmacodynamics of intra-articular isoflupredone following administration to horses with lipopolysaccharide-induced synovitis
title_sort pharmacokinetics and pharmacodynamics of intra articular isoflupredone following administration to horses with lipopolysaccharide induced synovitis
topic Horse
Isoflupredone
Corticosteroid
Pharmacokinetics
Pharmacodynamics
Inflammation
url https://doi.org/10.1186/s12917-022-03537-5
work_keys_str_mv AT heatherkknych pharmacokineticsandpharmacodynamicsofintraarticularisoflupredonefollowingadministrationtohorseswithlipopolysaccharideinducedsynovitis
AT danielweiner pharmacokineticsandpharmacodynamicsofintraarticularisoflupredonefollowingadministrationtohorseswithlipopolysaccharideinducedsynovitis
AT lindaharrison pharmacokineticsandpharmacodynamicsofintraarticularisoflupredonefollowingadministrationtohorseswithlipopolysaccharideinducedsynovitis
AT danielsmckemie pharmacokineticsandpharmacodynamicsofintraarticularisoflupredonefollowingadministrationtohorseswithlipopolysaccharideinducedsynovitis